Northside Hospital, Inc.

This study tests whether giving a drug called sargramostim after a half-matched stem cell transplant can help the body rebuild its immune system faster and lower the risk of serious infections. About 38 adults with blood cancers like leukemia or lymphoma will receive the drug aft…

This study tests whether giving the immune-suppressing drug tacrolimus earlier than usual can lower the risk of cytokine release syndrome (a severe immune reaction) in people receiving a half-matched stem cell transplant for blood cancer. About 20 adults will take part, and resea…

This study tests a stem cell transplant using a half-matched family donor for people with blood cancers. The goal is to see if this method helps the body accept the new cells and control the cancer. About 20 adults will receive a mild chemotherapy and radiation treatment before t…

This study tests a combination of two drugs, belumosudil and rituximab, as the first treatment for people with chronic graft-versus-host disease (cGVHD), a complication after a stem cell transplant. The goal is to see if this approach can control the disease and reduce the need f…

This study looks at whether CAR T cell therapy, a type of cancer treatment that uses a patient's own immune cells, can be safely given to people with moderate to severe kidney problems. About 20 adults with certain blood cancers (like lymphoma, myeloma, or leukemia) will receive …

This study tests a bone marrow transplant from a half-matched (haploidentical) donor for people with severe aplastic anemia, a rare condition where the bone marrow fails to make enough blood cells. The goal is to see if this approach can safely restore normal blood cell productio…

This study tests whether giving a specific type of chemotherapy (intrathecal) before and during treatment with the drug blinatumomab can prevent nerve-related side effects in adults with a type of leukemia called B-cell acute lymphoblastic leukemia. The trial involves 20 particip…